Location: Los Angeles, CA
CIK: 0001389933 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $240M (98.5% shares, 1.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | 13,680,554 | $41.31M | 17.2% | $0.97 | +327.6% | COM NEW | 85916J409 |
| — | BLUEPRINT MEDICINES CORP | 228,089 | $13.34M | 5.6% | $54.78 | — | COM | 09627Y109 |
| FATE | FATE THERAPEUTICS INC | 470,000 | $10.44M | 4.4% | $19.02 | +32.9% | COM | 31189P102 |
| GLPG | GALAPAGOS NV | 46,375 | $9.086M | 3.8% | $75.63 | — | SPON ADR | 36315X101 |
| DXCM | DEXCOM INC | 33,338 | $8.977M | 3.7% | $17.91 | +247.4% | COM | 252131107 |
| ATRC | ATRICURE INC | 239,729 | $8.052M | 3.4% | $13.70 | +162.5% | COM | 04963C209 |
| IBB | ISHARES TR NASDAQ BIOTECH | 72,900 | $7.854M | 3.3% | $119.23 | — | ETF | 464287556 |
| — | ARENA PHARMACEUTICALS INC | 179,642 | $7.545M | 3.1% | $40.90 | — | COM NEW | 040047607 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 80,208 | $6.942M | 2.9% | $67.74 | +44.5% | COM | 64125C109 |
| PRQR | PROQR THERAPEUTICS N V | 1,237,400 | $6.793M | 2.8% | $7.51 | +2.1% | SHS EURO | N71542109 |
| AKBA | AKEBIA THERAPEUTICS INC | 853,538 | $6.47M | 2.7% | $11.25 | -30.8% | COM | 00972D105 |
| — | LUMINEX CORP | 204,091 | $5.619M | 2.3% | $20.87 | — | COM | 55027E102 |
| — | CARA THERAPEUTICS INC | 371,033 | $4.901M | 2.0% | $17.77 | — | COM | 140755109 |
| — | SAGE THERAPEUTICS INC | 165,306 | $4.748M | 2.0% | $126.60 | — | COM | 78667J108 |
| CGEN | COMPUGEN LTD | 600,000 | $4.356M | 1.8% | $7.86 | 0.0% | ORD | M25722105 |
| — | AERIE PHARMACEUTICALS INC | 293,440 | $3.961M | 1.7% | $31.27 | — | COM | 00771V108 |
| XENE | XENON PHARMACEUTICALS INC | 346,535 | $3.93M | 1.6% | $9.56 | +49.0% | COM | 98420N105 |
| — | CORBUS PHARMACEUTICALS HLDGS | 747,300 | $3.916M | 1.6% | $5.70 | — | COM | 21833P103 |
| — | APPLIED GENETIC TECHNOL CORP | 1,160,878 | $3.808M | 1.6% | $6.02 | — | COM | 03820J100 |
| ASND | ASCENDIS PHARMA A S | 33,737 | $3.799M | 1.6% | $66.01 | — | SPONSORED ADR | 04351P101 |
| ALEC | ALECTOR INC | 155,000 | $3.74M | 1.6% | $18.66 | +36.6% | COM | 014442107 |
| — | ZOGENIX INC | 143,249 | $3.543M | 1.5% | $32.45 | — | COM NEW | 98978L204 |
| — | MIRATI THERAPEUTICS INC | 42,102 | $3.236M | 1.4% | $76.86 | — | COM | 60468T105 |
| — | BIOHAVEN PHARMACEUTICALS HOLD | 90,600 | $3.083M | 1.3% | $37.90 | — | COM | G11196105 |
| KURA | KURA ONCOLOGY INC | 307,541 | $3.06M | 1.3% | $13.81 | -17.1% | COM | 50127T109 |
| — | RADIUS HEALTH INC | 4,000,000 | $2.828M | 1.2% | $1.00 | — | NOTE 3.000% 9/0 | 750469AA6 |
| — | DICERNA PHARMACEUTICALS INC | 147,714 | $2.714M | 1.1% | $13.71 | — | COM | 253031108 |
| — | AXOVANT GENE THERAPIES LTD | 1,021,566 | $2.493M | 1.0% | $2.44 | — | COM | G0750W203 |
| — | MERSANA THERAPEUTICS INC | 401,619 | $2.341M | 1.0% | $5.23 | — | COM | 59045L106 |
| — | KADMON HOLDINGS INC | 556,564 | $2.332M | 1.0% | $3.15 | — | COM | 48283N106 |
| — | BIOTELEMETRY INC | 60,500 | $2.33M | 1.0% | $29.91 | — | COM | 090672106 |
| VKTX | VIKING THERAPEUTICS INC | 450,900 | $2.11M | 0.9% | $8.62 | -28.6% | COM | 92686J106 |
| — | TURNING POINT THERAPEUTICS I | 46,908 | $2.095M | 0.9% | $40.09 | — | COM | 90041T108 |
| — | CARDIOVASCULAR SYSTEMS INC | 51,200 | $1.803M | 0.8% | $32.10 | — | COM | 141619106 |
| KALV | KALVISTA PHARMACEUTICALS INC | 234,952 | $1.797M | 0.7% | $13.73 | -1.7% | COM | 483497103 |
| — | AFFIMED NV | 1,133,401 | $1.791M | 0.7% | $2.74 | — | COM | N01045108 |
| — | HARPOON THERAPEUTICS INC | 147,468 | $1.708M | 0.7% | $11.58 | — | COM | 41358P106 |
| — | EPIZYME INC | 105,900 | $1.643M | 0.7% | $13.61 | — | COM | 29428V104 |
| APLS | APELLIS PHARMACEUTICALS INC | 54,054 | $1.448M | 0.6% | $29.50 | +20.3% | COM | 03753U106 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 219,800 | $1.317M | 0.5% | $10.59 | — | SPON ADS | 05280R100 |
| ARAY | ACCURAY INC | 674,300 | $1.281M | 0.5% | $3.88 | -25.5% | COM | 004397105 |
| JNJ | JOHNSON AND JOHNSON | 9,400 | $1.233M | 0.5% | $59.66 | +101.4% | COM | 478160104 |
| INGN | INOGEN INC | 23,000 | $1.188M | 0.5% | $97.05 | -50.5% | COM | 45780L104 |
| — | BLUEBIRD BIO INC | 25,500 | $1.172M | 0.5% | $136.36 | — | COM | 09609G100 |
| — | ZYMEWORKS INC | 32,000 | $1.135M | 0.5% | $35.47 | — | COM | 98985W102 |
| — | PHASEBIO PHARMACEUTICALS INC | 320,542 | $1.061M | 0.4% | $7.12 | — | COM | 717224109 |
| ARDX | ARDELYX INC | 184,850 | $1.051M | 0.4% | $5.98 | +13.7% | COM | 039697107 |
| — | NATUS MEDICAL INC | 42,900 | $992K | 0.4% | $33.36 | — | COM | 639050103 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 479,051 | $958K | 0.4% | $5.49 | -49.9% | COM | 09058V103 |
| STIM | NEURONETICS INC | 495,772 | $937K | 0.4% | $6.60 | -52.6% | COM | 64131A105 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 542,564 | $933K | 0.4% | $5.22 | -61.3% | COM NEW | 372427401 |
| — | OTONOMY INC | 469,135 | $924K | 0.4% | $3.83 | — | COM | 68906L105 |
| — | PREVAIL THERAPEUTICS INC | 75,000 | $914K | 0.4% | $13.20 | — | COM | 74140Y101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 13,600 | $908K | 0.4% | $125.02 | -33.4% | COM | 558868105 |
| MGNX | MACROGENICS INC | 150,000 | $873K | 0.4% | $16.30 | -44.3% | COM | 556099109 |
| — | SYNLOGIC INC | 500,731 | $861K | 0.4% | $2.33 | — | COM | 87166L100 |
| CTMX | CYTOMX THERAPEUTICS INC | 100,000 | $767K | 0.3% | $9.86 | -29.3% | COM | 23284F105 |
| — | NEXTCURE INC | 20,000 | $741K | 0.3% | $56.35 | — | COM | 65343E108 |
| ARCT | ARCTURUS THERAPEUTICS HLDG I | 52,586 | $715K | 0.3% | $10.76 | +19.0% | COM | 03969T109 |
| — | DEXCOM INC | 250,000 | $687K | 0.3% | $1.15 | — | NOTE 0.750% 5/1 | 252131AF4 |
| — | TCR2 THERAPEUTICS INC | 78,786 | $610K | 0.3% | $7.74 | — | COM | 87808K106 |
| ARGX | ARGENX SE | 4,471 | $589K | 0.2% | $63.62 | — | SPONSORED ADR | 04016X101 |
| — | MORPHIC HOLDING INC | 37,000 | $543K | 0.2% | $17.16 | — | COM | 61775R105 |
| MASI | MASIMO CORPORATION | 3,000 | $531K | 0.2% | $43.65 | +292.9% | COM | 574795100 |
| — | ASSEMBLY BIOSCIENCES INC | 35,573 | $528K | 0.2% | $25.68 | — | COM | 045396108 |
| — | GAMIDA CELL LTD | 148,781 | $449K | 0.2% | $5.08 | — | SHS | M47364100 |
| — | KARUNA THERAPEUTICS INC | 6,231 | $449K | 0.2% | $72.06 | — | COM | 48576A100 |
| — | SUTRO BIOPHARMA INC | 40,000 | $408K | 0.2% | $13.14 | — | COM | 869367102 |
| — | EXICURE INC | 275,000 | $407K | 0.2% | $2.86 | — | COM | 30205M101 |
| SPRO | SPERO THERAPEUTICS INC | 48,103 | $389K | 0.2% | $8.81 | 0.0% | COM | 84833T103 |
| RCUS | ARCUS BIOSCIENCES INC | 27,798 | $386K | 0.2% | $12.44 | 0.0% | COM | 03969F109 |
| — | ELOXX PHARMACEUTICALS INC | 191,494 | $375K | 0.2% | $9.97 | — | COM | 29014R103 |
| — | GRITSTONE ONCOLOGY INC | 50,000 | $291K | 0.1% | $11.14 | — | COM | 39868T105 |
| — | RADIUS HEALTH INC | 22,000 | $286K | 0.1% | $21.68 | — | COM NEW | 750469207 |
| — | RIGEL PHARMACEUTICALS INC | 157,700 | $246K | 0.1% | $3.40 | — | COM NEW | 766559603 |
| — | ZAFGEN INC | 305,500 | $235K | 0.1% | $4.13 | — | COM | 98885E103 |
| — | BIOXCEL THERAPEUTICS INC | 4,614 | $103K | 0.0% | $22.32 | — | COM | 09075P105 |
| — | ASLAN PHARMACEUTICALS LTD | 86,082 | $88,000 | 0.0% | $2.03 | — | ADS | 04522R101 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 95,000 | $79,000 | 0.0% | $1.03 | -3.4% | COM | 53566P109 |
| URGN | UROGEN PHARMA LTD | 2,369 | $42,000 | 0.0% | $51.86 | -47.9% | COM | M96088105 |